The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry

  • Kim, Hyun Kuk (The Heart Center, Chonnam National University Hospital) ;
  • Jeong, Myung Ho (The Heart Center, Chonnam National University Hospital) ;
  • Lee, Seung Hun (The Heart Center, Chonnam National University Hospital) ;
  • Sim, Doo Sun (The Heart Center, Chonnam National University Hospital) ;
  • Hong, Young Joon (The Heart Center, Chonnam National University Hospital) ;
  • Ahn, Youngkeun (The Heart Center, Chonnam National University Hospital) ;
  • Kim, Chong Jin (Cardiovascular Center, Kyung Hee University Hospital at Gangdong) ;
  • Cho, Myeong Chan (Cardiovascular Center, Chungbuk National University Hospital) ;
  • Kim, Young Jo (Cardiovascular Center, Yeungnam University Medical Center)
  • Received : 2014.08.17
  • Accepted : 2014.09.08
  • Published : 2014.11.01
⟨ Previous Next ⟩

Abstract

The Korea Acute Myocardial Infarction Registry (KAMIR) was the first nationwide registry data collection designed to track outcomes of patients with acute myocardial infarction (AMI). These studies reflect the current therapeutic approaches and management for AMI in Korea. The results of KAMIR could help clinicians to predict the prognosis of their patients and identify better diagnostic and treatment tools to improve the quality of care. The KAMIR score was proposed to be a predictor of the prognosis of AMI patients. Triple antiplatelet therapy, consisting of aspirin, clopidogrel and cilostazol, was effective at preventing major adverse clinical outcomes. Drug-eluting stents were effective and safe in AMI patients with no increased risk of stent thrombosis. Statin therapy was effective in Korean AMI patients, including those with very low levels of low density cholesterol. The present review summarizes the 10-year scientific achievements of KAMIR from admission to outpatient care during long-term clinical follow-up.

Keywords

Acknowledgement

Supported by : Ministry for Health and Welfare

References

  1. Kim HK, Jeong MH, Ahn Y, et al. A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction. Int J Cardiol 2010;145:450-454. https://doi.org/10.1016/j.ijcard.2009.06.001
  2. Kim HK, Jeong MH, Ahn Y, et al. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score). Am J Cardiol 2011;107:965.e1-971.e1.
  3. Kim KH, Kim W, Hwang SH, et al. The CHADSVASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation. J Cardiol 2014 Jun 24 [Epub]. http://dx.doi.org/10.1016/j.jjcc.2014.04.011.
  4. Jeong YW, Jeong MH, Kim SS, et al. CHA2DS2-VASc scoring system as an initial method for screening highrisk patients in acute myocardial infarction. Int J Cardiol 2014;174:777-780. https://doi.org/10.1016/j.ijcard.2014.04.055
  5. Cho JY, Jeong MH, Ahn Y, et al. Impact of high admission blood pressure without history of hypertension on clinical outcomes of patients with acute myocardial infarction: from Korea Acute Myocardial Infarction Registry. Int J Cardiol 2014;172:e54-e58. https://doi.org/10.1016/j.ijcard.2013.12.063
  6. Kang DG, Jeong MH, Ahn Y, et al. Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J Korean Med Sci 2009;24:800-806. https://doi.org/10.3346/jkms.2009.24.5.800
  7. Li YJ, Rha SW, Chen KY, et al. Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: lessons from the Korea Acute Myocardial Infarction Registry. Clin Exp Pharmacol Physiol 2010;37:581-586. https://doi.org/10.1111/j.1440-1681.2010.05363.x
  8. Kim C, Chang HJ, Cho I, et al. Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry. Korean J Intern Med 2013;28:547-556. https://doi.org/10.3904/kjim.2013.28.5.547
  9. Kang SH, Suh JW, Choi DJ, et al. Cigarette smoking is paradoxically associated with low mortality risk after acute myocardial infarction. Nicotine Tob Res 2013;15:1230-1238. https://doi.org/10.1093/ntr/nts248
  10. Chen KY, Rha SW, Li YJ, et al. 'Smoker's paradox' in young patients with acute myocardial infarction. Clin Exp Pharmacol Physiol 2012;39:630-635. https://doi.org/10.1111/j.1440-1681.2012.05721.x
  11. Kang WY, Jeong MH, Ahn YK, et al. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Cardiol 2010;55:84-91. https://doi.org/10.1016/j.jjcc.2009.10.004
  12. Lee SH, Park JS, Kim W, et al. Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry). Am J Cardiol 2008;102:957-965. https://doi.org/10.1016/j.amjcard.2008.06.022
  13. Park HW, Yoon CH, Kang SH, et al. Early- and lateterm clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. Int J Cardiol 2013;169:254-261. https://doi.org/10.1016/j.ijcard.2013.08.132
  14. Song YB, Hahn JY, Kim JH, et al. Comparison of angiographic and other findings and mortality in non-STsegment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention. Am J Cardiol 2010;106:1397-1403. https://doi.org/10.1016/j.amjcard.2010.07.010
  15. Kim SS, Jeong MH, Rhew SH, et al. Impact of patients' arrival time on the care and in-hospital mortality in patients with non-ST-elevation myocardial infarction. Am J Cardiol 2014;113:262-269. https://doi.org/10.1016/j.amjcard.2013.09.013
  16. Park HE, Koo BK, Lee W, et al. Periodic variation and its effect on management and prognosis of Korean patients with acute myocardial infarction. Circ J 2010;74:970-976. https://doi.org/10.1253/circj.CJ-09-0344
  17. Song YB, Hahn JY, Gwon HC, et al. The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry. J Korean Med Sci 2008;23:357-364. https://doi.org/10.3346/jkms.2008.23.3.357
  18. Lee JH, Chae SC, Yang DH, et al. Influence of weather on daily hospital admissions for acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Int J Cardiol 2010;144:16-21. https://doi.org/10.1016/j.ijcard.2009.03.122
  19. Cho JY, Jeong MH, Ahn YK, et al. Comparison of outcomes of patients with painless versus painful ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2012;109:337-343. https://doi.org/10.1016/j.amjcard.2011.09.017
  20. Choi JS, Kim CS, Park JW, et al. Renal dysfunction as a risk factor for painless myocardial infarction: results from Korea Acute Myocardial Infarction Registry. Clin Res Cardiol 2012;101:795-803. https://doi.org/10.1007/s00392-012-0461-1
  21. Kwon TG, Bae JH, Jeong MH, et al. N-terminal pro- B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol 2009;133:173-178. https://doi.org/10.1016/j.ijcard.2007.12.022
  22. Kim CS, Kim MJ, Kang YU, et al. Inf luence of renal dysfunction on clinical outcomes in patients with congestive heart failure complicating acute myocardial infarction. Int Heart J 2013;54:304-310. https://doi.org/10.1536/ihj.54.304
  23. Kang YU, Kim MJ, Choi JS, et al. Concomitant impact of high-sensitivity C-reactive protein and renal dysfunction in patients with acute myocardial infarction. Yonsei Med J 2014;55:132-140. https://doi.org/10.3349/ymj.2014.55.1.132
  24. Lee SH, Kim YJ, Kim W, et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J 2008;72:1410-1418. https://doi.org/10.1253/circj.CJ-08-0088
  25. Seo SM, Kim TH, Kim CJ, et al. Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention. Coron Artery Dis 2012;23:307-314. https://doi.org/10.1097/MCA.0b013e3283519f25
  26. Sim DS, Ahn Y, Jeong MH, et al. Clinical outcome of unprotected left main coronary artery disease in patients with acute myocardial infarction. Int Heart J 2013;54:185-191. https://doi.org/10.1536/ihj.54.185
  27. Kim U, Park JS, Kang SW, et al. Outcomes according to presentation with versus without cardiogenic shock in patients with left main coronary artery stenosis and acute myocardial infarction. Am J Cardiol 2012;110:36-39. https://doi.org/10.1016/j.amjcard.2012.02.044
  28. Baek JY, Seo SM, Park HJ, et al. Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction. Catheter Cardiovasc Interv 2014;83:E243-E250. https://doi.org/10.1002/ccd.23420
  29. Kim MC, Ahn Y, Rhew SH, et al. Impact of total occlusion of an infarct-related artery on long-term mortality in acute non-ST-elevation myocardial infarction patients who underwent early percutaneous coronary intervention. Int Heart J 2012;53:160-164. https://doi.org/10.1536/ihj.53.160
  30. Kim SS, Choi HS, Jeong MH, et al. Clinical outcomes of acute myocardial infarction with occluded left circumflex artery. J Cardiol 2011;57:290-296. https://doi.org/10.1016/j.jjcc.2011.01.014
  31. Kang WY, Jeong MH, Ahn YK, et al. Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe? Int J Cardiol 2011;146:207-212. https://doi.org/10.1016/j.ijcard.2009.07.001
  32. Jeong HC, Ahn YK, Jeong MH, et al. Intensive pharmacologic treatment in patients with acute non ST-segment elevation myocardial infarction who did not undergo percutaneous coronary intervention. Circ J 2008;72:1403-1409. https://doi.org/10.1253/circj.CJ-08-0048
  33. Choo EH, Chang K, Ahn Y, et al. Benefit of beta-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention. Heart 2014;100:492-499. https://doi.org/10.1136/heartjnl-2013-305137
  34. Jeong HC, Jeong MH, Ahn Y, et al. Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonist. Int J Cardiol 2014;170:291-297. https://doi.org/10.1016/j.ijcard.2013.07.146
  35. Jeong HC, Jeong JM, Jeong MH, et al. Effect of single or dual blockade of renin-angiotensin system in acute myocardial infarction patients according to renal function. Int J Cardiol 2012;157:408-411. https://doi.org/10.1016/j.ijcard.2012.03.141
  36. Kim JS, Kim CH, Chun KJ, et al. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry. Clin Res Cardiol 2013;102:915-922. https://doi.org/10.1007/s00392-013-0611-0
  37. Yang MJ, Lee HC, Lee HW, et al. Effect of nicorandil on clinical outcomes in patients with ST-segment elevation and non-ST-segment elevation myocardial infarction: based on the Korea Acute Myocardial Infarction Registry (KAMIR). Int J Cardiol 2013;168:4868-4869. https://doi.org/10.1016/j.ijcard.2013.07.055
  38. Kim JY, Jeong MH, Moon JH, et al. Impact of Clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 2012;110:1598-1606. https://doi.org/10.1016/j.amjcard.2012.07.025
  39. Choi CU, Rha SW, Oh DJ, et al. Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry. Am Heart J 2011;161:373.e1-3-382.e1-3.
  40. Cho JS, Her SH, Baek JY, et al. Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor. J Korean Med Sci 2010;25:1601-1608. https://doi.org/10.3346/jkms.2010.25.11.1601
  41. Li YJ, Rha SW, Chen KY, et al. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J 2010;159:684.e1-690.e1.
  42. Li YJ, Rha SW, Chen KY, et al. Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents. J Cardiol 2012;59:22-29. https://doi.org/10.1016/j.jjcc.2011.09.005
  43. Sim DS, Jeong MH, Ahn Y, et al. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2009;103:1333-1338. https://doi.org/10.1016/j.amjcard.2009.01.339
  44. Sim DS, Jeong MH, Ahn Y, et al. Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction. Am J Cardiol 2012;110:1275-1281. https://doi.org/10.1016/j.amjcard.2012.06.028
  45. Kim MC, Jeong MH, Ahn Y, et al. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization. Int J Cardiol 2011;153:148-153. https://doi.org/10.1016/j.ijcard.2010.08.044
  46. Lee HW, Hong TJ, Yang MJ, et al. Comparison of infarct- related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry. Cardiol J 2012;19:256-266. https://doi.org/10.5603/CJ.2012.0047
  47. Hong YJ, Jeong MH, Ahn Y, Kang JC. The efficacy and safety of drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction (KAMIR). Int J Cardiol 2013;163:1-4. https://doi.org/10.1016/j.ijcard.2012.02.003
  48. Sim DS, Jeong MH, Ahn Y, et al. Ef fectiveness of drug-eluting stents versus bare-metal stents in large coronary arteries in patients with acute myocardial infarction. J Korean Med Sci 2011;26:521-527. https://doi.org/10.3346/jkms.2011.26.4.521
  49. Bae EH, Lim SY, Choi YH, et al. Drug-eluting vs. bare-metal stents for treatment of acute myocardial infarction with renal insuff iciency: results from Korea Acute Myocardial Infarction Registry. Circ J 2011;75:2798-2804. https://doi.org/10.1253/circj.CJ-11-0586
  50. Lee SR, Jeong MH, Ahn YK, et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J 2008;72:392-398. https://doi.org/10.1253/circj.72.392
  51. Cho Y, Yang HM, Park KW, et al. Paclitaxel- versus sirolimus- eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation. JACC Cardiovasc Interv 2010;3:498-506. https://doi.org/10.1016/j.jcin.2010.02.011
  52. Kim HK, Jeong MH, Ahn YK, et al. Comparison of outcomes between Zotarolimus- and sirolimus-eluting stents in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 2010;105:813-818. https://doi.org/10.1016/j.amjcard.2009.11.009
  53. Lee MG, Jeong MH, Ahn Y, et al. Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome. Circ J 2011;75:2120-2127. https://doi.org/10.1253/circj.CJ-11-0263
  54. Chen KY, Rha SW, Wang L, et al. Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity scorematched analysis. JACC Cardiovasc Interv 2012;5:936-945. https://doi.org/10.1016/j.jcin.2012.05.009
  55. Cho SC, Jeong MH, Kim W, et al. Clinical outcomes of everolimus- and zotarolimus-eluting stents in patients with acute myocardial infarction for small coronary artery disease. J Cardiol 2014;63:409-417. https://doi.org/10.1016/j.jjcc.2013.10.016
  56. Ahmed K, Jeong MH, Chakraborty R, et al. Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011;108:8-14. https://doi.org/10.1016/j.amjcard.2011.02.339
  57. Hachinohe D, Jeong MH, Saito S, et al. Clinical impact of thrombus aspiration during primary percutaneous coronary intervention: results from Korea Acute Myocardial Infarction Registry. J Cardiol 2012;59:249-257. https://doi.org/10.1016/j.jjcc.2011.12.005
  58. Lee JH, Yang DH, Park HS, et al. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J 2010;159:1012-1019. https://doi.org/10.1016/j.ahj.2010.03.009
  59. Lee JH, Park HS, Chae SC, et al. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol 2009;104:182-189. https://doi.org/10.1016/j.amjcard.2009.03.010
  60. Lee CH, Lee SH, Park JS, et al. Impact of statin usage patterns on outcomes after percutaneous coronary intervention in acute myocardial infarction: Korea Working Group on Myocardial Infarction registry (KorMI) study. J Geriatr Cardiol 2014;11:93-99.
  61. Cho KH, Jeong MH, Ahn Y, et al. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox). Am J Cardiol 2010;106:1061-1068. https://doi.org/10.1016/j.amjcard.2010.06.009
  62. Lee KH, Jeong MH, Kim HM, et al. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol. J Am Coll Cardiol 2011;58:1664-1671. https://doi.org/10.1016/j.jacc.2011.05.057
  63. Jeong HC, Ahn Y, Hong YJ, et al. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein. Int J Cardiol 2013;167:1848-1853. https://doi.org/10.1016/j.ijcard.2012.04.123
  64. Lim SY, Bae EH, Choi JS, et al. Effect on short- and long-term major adverse cardiac events of statin treatment in patients with acute myocardial infarction and renal dysfunction. Am J Cardiol 2012;109:1425-1430. https://doi.org/10.1016/j.amjcard.2012.01.351
  65. Chen KY, Rha SW, Li YJ, et al. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 2009;119:3207-3214. https://doi.org/10.1161/CIRCULATIONAHA.108.822791
  66. Choo EH, Kim PJ, Chang K, et al. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality. Coron Artery Dis 2014;25:392-398. https://doi.org/10.1097/MCA.0000000000000108
  67. Lee KH, Ahn Y, Kim SS, et al. Comparison of triple anti-platelet therapy and dual anti-platelet therapy in patients with acute myocardial infarction who had no-reflow phenomenon during percutaneous coronary intervention. Circ J 2013;77:2973-2981. https://doi.org/10.1253/circj.CJ-13-0594
  68. Korea Acute Myocardial Infarction Registry (KAMIR) Investigators, Lee KH, Jeong MH, et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008;130:227-234. https://doi.org/10.1016/j.ijcard.2007.08.044
  69. Park JS, Kim YJ, Shin DG, et al. Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR) study. Clin Cardiol 2010;33:E1-E6.
  70. Woo JS, Kim W, Ha SJ, Kim SJ, Kang WY, Jeong MH. Impact of gender differences on long-term outcomes after successful percutaneous coronary intervention in patients with acute myocardial infarction. Int J Cardiol 2010;145:516-518. https://doi.org/10.1016/j.ijcard.2010.02.028
  71. Kang SH, Suh JW, Yoon CH, et al. Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry). Am J Cardiol 2012;109:787-793. https://doi.org/10.1016/j.amjcard.2011.11.006
  72. Kim HL, Kang SH, Yoon CH, et al. Differential prognostic impacts of diabetes over time course after acute myocardial infarction. J Korean Med Sci 2013;28:1749-1755. https://doi.org/10.3346/jkms.2013.28.12.1749
  73. Park KH, Ahn Y, Jeong MH, et al. Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry. Korean J Intern Med 2012;27:180-188. https://doi.org/10.3904/kjim.2012.27.2.180
  74. Yang JH, Song PS, Song YB, et al. Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock. Crit Care 2013;17:R218. https://doi.org/10.1186/cc13035
  75. Lee SA, Cho SJ, Jeong MH, et al. Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patients. Diabetes Care 2014;37:2366-2373. https://doi.org/10.2337/dc13-2856
  76. Lee MG, Jeong MH, Ahn Y, et al. Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction. J Korean Med Sci 2010;25:1456-1461. https://doi.org/10.3346/jkms.2010.25.10.1456
  77. Lee MG, Jeong MH, Ahn Y, et al. Additive impact of diabetes mellitus on patients with metabolic syndrome and acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol 2012;157:283-285. https://doi.org/10.1016/j.ijcard.2012.03.102
  78. Kim CS, Choi JS, Bae EH, et al. Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction. Metabolism 2013;62:669-676. https://doi.org/10.1016/j.metabol.2012.11.002
  79. Ahmed K, Jeong MH, Chakraborty R, et al. Percutaneous coronary intervention with drug-eluting stent implantation vs. coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction. Circ J 2012;76:721-728. https://doi.org/10.1253/circj.CJ-11-1013
  80. Bae EH, Lim SY, Cho KH, et al. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 2012;59:795-802. https://doi.org/10.1053/j.ajkd.2012.01.016
  81. Choi JS, Kim CS, Bae EH, et al. Predicting outcomes after myocardial infarction by using the Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease study equation: results from the Korea Acute Myocardial Infarction Registry. Nephrol Dial Transplant 2012;27:3868-3874. https://doi.org/10.1093/ndt/gfs344
  82. Choi JS, Kim MJ, Kang YU, et al. Association of age and CKD with prognosis of myocardial infarction. Clin J Am Soc Nephrol 2013;8:939-944. https://doi.org/10.2215/CJN.06930712
  83. Choi JS, Kim CS, Bae EH, et al. Suboptimal medical care of patients with ST-elevation myocardial infarction and renal insuff iciency: results from the Korea Acute Myocardial Infarction Registry. BMC Nephrol 2012;13:110. https://doi.org/10.1186/1471-2369-13-110
  84. Hachinohe D, Jeong MH, Saito S, et al. Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol 2011;108:206-213. https://doi.org/10.1016/j.amjcard.2011.03.025
  85. Lim SY, Bae EH, Choi JS, et al. Percutaneous coronary intervention for acute myocardial infarction in elderly patients with renal dysfunction: results from the Korea Acute Myocardial Infarction Registry. J Korean Med Sci 2013;28:1027-1033. https://doi.org/10.3346/jkms.2013.28.7.1027
  86. Piao ZH, Jeong MH, Jin L, et al. Clinical impact of early intervention in octogenarians with non-ST-elevation myocardial infarction. Int J Cardiol 2014;172:462-464. https://doi.org/10.1016/j.ijcard.2013.12.282
  87. Lee KH, Ahn Y, Kim SS, et al. Characteristics, in-hospital and long-term clinical outcomes of nonagenarian compared with octogenarian acute myocardial infarction patients. J Korean Med Sci 2014;29:527-535. https://doi.org/10.3346/jkms.2014.29.4.527
  88. Yamanaka F, Jeong MH, Saito S, et al. Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: analysis of the Korean Acute Myocardial Infarction Registry. J Cardiol 2013;62:210-216. https://doi.org/10.1016/j.jjcc.2013.04.003
  89. Yoo YP, Kang KW, Yoon HS, et al. One-year clinical outcomes in invasive treatment strategies for acute ST-elevation myocardial infarction complicated by cardiogenic shock in elderly patients. J Geriatr Cardiol 2013;10:235-241.

Cited by

  1. Mortality Trends of Cardiovascular Disease in Korea; Big Challenges in Ischemic Heart Disease vol.45, pp.3, 2014, https://doi.org/10.4070/kcj.2015.45.3.192
  2. Thirty-Year Trends in Mortality from Cardiovascular Diseases in Korea vol.45, pp.3, 2014, https://doi.org/10.4070/kcj.2015.45.3.202
  3. Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure vol.10, pp.12, 2014, https://doi.org/10.1371/journal.pone.0144602
  4. Gender differences in risk factors and clinical outcomes in young patients with acute myocardial infarction vol.70, pp.11, 2014, https://doi.org/10.1136/jech-2015-207023
  5. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction : A Propensity Score–Matched Analysis vol.9, pp.9, 2016, https://doi.org/10.1161/circinterventions.115.003508
  6. Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction vol.48, pp.6, 2014, https://doi.org/10.4070/kcj.2017.0128
  7. The contribution of gender and age on early and late mortality following ST-segment elevation myocardial infarction: results from the Korean Acute Myocardial Infarction National Registry with Registri vol.15, pp.3, 2014, https://doi.org/10.11909/j.issn.1671-5411.2018.03.001
  8. Building a Longitudinal National Integrated Cardiovascular Database ― Lessons Learnt From SingCLOUD ― vol.2, pp.1, 2014, https://doi.org/10.1253/circrep.cr-19-0106
  9. Clinical Benefit of Statins in Korean Patients with Acute Myocardial Infarction: Experience of the Korea Acute Myocardial Infarction Registry vol.9, pp.3, 2020, https://doi.org/10.12997/jla.2020.9.3.362
  10. Pharmacotherapy for acute myocardial infarction vol.64, pp.2, 2021, https://doi.org/10.5124/jkma.2021.64.2.139